SCHEMBL19257770

SCHEMBL19257770

CCCC(C)Oc1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.33

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.33
CCNB2 O95067 1/20 0.30
CCNE2 O96020 1/20 0.30
CDK1 P06493 1/20 0.30
CCNB1 P14635 1/20 0.30
CCNE1 P24864 1/20 0.30
CDK2 P24941 1/20 0.30
CCNB3 Q8WWL7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20226628 0.88 MCHR1 (0.36) MCHR1
SCHEMBL10183185 0.81 PKM (0.32)
SCHEMBL20226560 0.77 MCHR1 (0.35) MCHR1
SCHEMBL22970316 0.76 PRKCA (0.31)
SCHEMBL20149566 0.72 MCHR1 (0.37) MCHR1
SCHEMBL9425535 0.71
SCHEMBL14261957 0.70 FAAH (0.31)
SCHEMBL10259660 0.69 CA1 (0.31)
SCHEMBL14627757 0.69 CRHR1 (0.30)
SCHEMBL26318965 0.69 TSHR (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017134547-A1 TUBULYSIN ANALOGS AND METHODS FOR THEIR PREPARATION PFIZER INC. (US) 2017-08-10 WO disclosed
CN-102947319-B Method and tertiary phosphine for phosphine oxides is reduced into corresponding tertiary phosphine in the presence of a catalyst is used for reducing in the presence of a catalyst the purposes of phosphine oxides 克罗马福拉公司 2016-11-09 CN disclosed
CN-102947319-A A process for the reduction of a tertiary phosphine oxide to the corresponding tertiary phosphine in the presence of a catalyst and use of a tertiary phosphine for reducing a tertiary phosphine oxide in the presence of a catalyst CHROMAFORA AB 2013-02-27 CN disclosed